Compare EVO & PLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVO | PLAB |
|---|---|---|
| Founded | 1993 | 1969 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 2021 | 1987 |
| Metric | EVO | PLAB |
|---|---|---|
| Price | $2.98 | $36.79 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $7.00 | ★ $43.50 |
| AVG Volume (30 Days) | 107.8K | ★ 1.8M |
| Earning Date | 11-05-2025 | 12-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 9.09 |
| EPS | N/A | ★ 2.28 |
| Revenue | ★ $887,396,457.00 | $849,294,000.00 |
| Revenue This Year | N/A | $4.63 |
| Revenue Next Year | $8.80 | $6.20 |
| P/E Ratio | ★ N/A | $15.93 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.84 | $16.46 |
| 52 Week High | $5.10 | $39.80 |
| Indicator | EVO | PLAB |
|---|---|---|
| Relative Strength Index (RSI) | 40.01 | 78.97 |
| Support Level | $2.86 | $35.69 |
| Resistance Level | $3.09 | $39.80 |
| Average True Range (ATR) | 0.10 | 1.61 |
| MACD | 0.01 | 1.71 |
| Stochastic Oscillator | 24.49 | 83.24 |
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
Photronics Inc is a U.S.-based company that is principally engaged in manufacturing photomasks. The photomasks are photographic quartz or glass plates that contain microscopic images of electronic circuits that are used as a component in the manufacture of integrated circuits and flat-panel displays. The revenue from products designed for integrated circuits production accounts for the majority of total revenue, with the rest derived from products for flat-panel display production. The company's assets are located in Taiwan, Korea, and the United States. It generates revenue world-wide, including in the United States, Europe, Taiwan, Korea, China, and elsewhere in Asia, with Taiwan contributing the majority of total revenue.